Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD is a paper indexed in PICO Portal from OpenAlex.
How many citations does Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD have?
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD has 327 citations in the OpenAlex counts PICO Portal stores.
When was Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD published?
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD has 2016 year in the PICO Portal index.
What is the open-access status of Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD?
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD has hybrid oa status in the PICO Portal index.
What is the DOI of Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD?
The DOI for Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD is on the source record.
What is the PMID of Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD?
The PMID for Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD is on the source record.
What is the OpenAlex record for Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD?
The OpenAlex for Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD is on the source record.